Clinical effectiveness and cost-effectiveness of teledermatology: Where are we now, and what are the barriers to adoption?
Wang RH, Barbieri JS, Nguyen HP, Stavert R, Forman HP, Bolognia JL, Kovarik CL, Dermatology F. Clinical effectiveness and cost-effectiveness of teledermatology: Where are we now, and what are the barriers to adoption? Journal Of The American Academy Of Dermatology 2020, 83: 299-307. PMID: 32035106, PMCID: PMC7302990, DOI: 10.1016/j.jaad.2020.01.065.Peer-Reviewed Original ResearchMeSH KeywordsCenters for Medicare and Medicaid Services, U.S.Cost-Benefit AnalysisDermatologyHealth Plan ImplementationHealth PolicyHealth Services AccessibilityHumansInsurance, Health, ReimbursementSkin DiseasesTelemedicineTreatment OutcomeUnited StatesConceptsPatient careHigh-quality dermatologic carePractice-level barriersClinical efficacyClinical effectivenessCare settingsDermatologic careCare deliveryMedicaid ServicesTeledermatology servicesTeledermatology implementationTeledermatologyCareTelemedicine reimbursementDermatologistsPotential implications